Richard Segal

Richard Segal, R.Ph., Ph.D., M.S.

Professor

Department: Dean's Office
Business Phone: (352) 273-6265
Business Email: segal@cop.ufl.edu

About Richard Segal

Richard Segal, Ph.D., is a professor of Pharmaceutical Outcomes & Policy at the University of Florida College of Pharmacy and also holds a faculty appointment in the Department of Pharmacotherapy and Translational Research. His research interests focuses on improving the quality and safety of the medication use process, with a particular emphasis on improving prescribing practices and in creating collaborative practice models to improve medication use by patients.

Segal is widely recognized for his work in explaining why clinical practice is so often inconsistent with evidence-based best practices. His research in the area of changing prescribing behavior has been the basis of prescribing interventions throughout the world. Segal was Co-PI on the first major research project focused on training community pharmacists to identify and prevent drug related problems which contribute to preventable drug related morbidity called Therapeutic Outcomes Monitoring (TOM). Their research has helped to shape many medication therapy management interventions used by health plans in the United States and in other countries.

Accomplishments

Outstanding Team Teaching Award, Course Coordinator
2017 · University of Florida
Silver and Gold Awards for Best Research Poster
2015-2018 · Amiercan Managed Care Pharmacy
APHA-APRS 'Postgraduate Best Paper Award' in the Clinical Sciences section
2004 · American Pharmacists Association
"Best of Blue" National Research Award
2001 · Blue Cross Blue Shield
Best Published Paper Award
1999 · American Pharmaceutical Association
Award for Practice Research
1997 · American Society of Health-Systems Pharmacy

Research Profile

Dr. Segal’s research focuses on improving the quality and safety of the medication use process, with a particular emphasis on improving prescribing practices and in creating collaborative practice models to improve medication use by patients.

Open Researcher and Contributor ID (ORCID)

0000-0002-7253-8227

Publications

2021
Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida.
Journal of psychoactive drugs. 1-10 [DOI] 10.1080/02791072.2020.1864069. [PMID] 33393877.
2020
The Pharmacist as an LGBTQ Ally.
American journal of pharmaceutical education. 84(7) [DOI] 10.5688/ajpe7835. [PMID] 32773835.
2020
Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
JAMA network open. 3(6) [DOI] 10.1001/jamanetworkopen.2020.8968. [PMID] 32579194.
2020
Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009-2014.
Journal of psychosomatic obstetrics and gynaecology. 1-7 [DOI] 10.1080/0167482X.2020.1727882. [PMID] 32067526.
2020
Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry.
Journal of clinical medicine. 9(4) [DOI] 10.3390/jcm9041166. [PMID] 32325769.
2020
Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States.
Journal of infection and public health. 13(1):101-103 [DOI] 10.1016/j.jiph.2019.06.010. [PMID] 31279802.
2020
Opportunities and responsibilities for pharmacists to improve their effectiveness in addressing medication adherence through culturally sensitive collaborations with community health workers.
Journal of the American Pharmacists Association : JAPhA. 60(4):e25-e30 [DOI] 10.1016/j.japh.2020.02.023. [PMID] 32217086.
2019
Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis.
Pharmacotherapy. 39(9):912-920 [DOI] 10.1002/phar.2311. [PMID] 31332815.
2019
Impacting Student Self-Efficacy and Beliefs of Medication Therapy Management Through a Two-Week Elective.
American journal of pharmaceutical education. 83(5) [DOI] 10.5688/ajpe6995. [PMID] 31333264.
2019
Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.
Pharmacoepidemiology and drug safety. 28(9):1222-1230 [DOI] 10.1002/pds.4843. [PMID] 31286606.
2018
Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched Analysis.
World neurosurgery. 120:e42-e52 [DOI] 10.1016/j.wneu.2018.07.125. [PMID] 30170146.
2018
Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.
Pharmacoepidemiology and drug safety. 27(6):587-595 [DOI] 10.1002/pds.4405. [PMID] 29512263.
2018
Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy.
Journal of child and adolescent psychopharmacology. 28(2):111-116 [DOI] 10.1089/cap.2017.0110. [PMID] 29028437.
2018
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.
Clinical therapeutics. 40(4):613-626.e1 [DOI] 10.1016/j.clinthera.2018.03.006. [PMID] 29609879.
2017
Trends in Antiepileptic Drug Use in Children and Adolescents With Epilepsy.
Pediatric neurology. 74:32-40 [DOI] 10.1016/j.pediatrneurol.2017.05.016. [PMID] 28676250.
2017
Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: A machine learning approach.
Heart & lung : the journal of critical care. 46(6):405-411 [DOI] 10.1016/j.hrtlng.2017.09.003. [PMID] 28992993.
2017
Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Journal of managed care & specialty pharmacy. 23(1):13-21 [DOI] 10.18553/jmcp.2017.23.1.13. [PMID] 28025924.
2017
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.
BMC pregnancy and childbirth. 17(1) [DOI] 10.1186/s12884-016-1190-7. [PMID] 28061833.
2017
Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(21):1774-1783 [DOI] 10.2146/ajhp160387. [PMID] 29070499.
2017
Duration of Reproductive Years and the Risk of Cardiovascular and Cerebrovascular Events in Older Women: Insights from the National Health and Nutrition Examination Survey.
Journal of women's health (2002). 26(10):1047-1052 [DOI] 10.1089/jwh.2016.6013. [PMID] 28525295.
2016
Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study.
Pediatrics. 137(5) [DOI] 10.1542/peds.2015-3199. [PMID] 27244795.
2016
Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides.
Pharmacoepidemiology and drug safety. 25(6):678-86 [DOI] 10.1002/pds.3894. [PMID] 26597624.
2016
What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?
Papillomavirus research (Amsterdam, Netherlands). 2:46-51 [DOI] 10.1016/j.pvr.2016.02.001. [PMID] 29074185.
2015
Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 18(2):260-70 [DOI] 10.1016/j.jval.2014.11.007. [PMID] 25773561.
2015
Discussion Between Providers and Patients About Prostate Specific Antigen Testing in Usa
Value in Health. 18(3)
2014
Pharmacists’ perspective on providing care when patients engage in unhealthy behaviors.
Journal of the American Pharmacists Association : JAPhA. 54(2):159-62 [DOI] 10.1331/JAPhA.2014.13149. [PMID] 24562598.
2014
Comparison of Rates of Prescribing Oral Corticosteroids for Asthma Exacerbations Between Step-Down Therapy Approaches Among Initiators of Inhaled Corticosteroids and Long-Acting Beta-Agonist Combination Therapy
. 133(2, S)
2014
Epidemiology of Pre-Existing Diabetes in Pregnancy From 2000-2006 Among Medicaid Patients in 29 Us States
Pharmacoepidemiology and Drug Safety. 23(1, SI)
2014
Modern utilization of penile prosthesis surgery: a national claim registry analysis.
International journal of impotence research. 26(5):167-71 [DOI] 10.1038/ijir.2014.11. [PMID] 24830674.
2014
Predicting Linkage Within a Validated Algorithm That Identifies Mother-Infant Pairs Within the Medicaid Analytic Extract (Max) Database
Pharmacoepidemiology and Drug Safety. 23(1, SI)
2014
Risk of Sudden Sensorineural Hearing Loss in Adults Using Phosphodiesterase Type 5 Inhibitors
Pharmacoepidemiology and Drug Safety. 23(1, SI):492-493
2014
Reliability and validity for the measurement of moral disengagement in pharmacists.
Research in social & administrative pharmacy : RSAP. 10(2):297-312 [DOI] 10.1016/j.sapharm.2013.06.006. [PMID] 23891105.
2013
Long-Acting Beta-Agonists and Asthma Exacerbations Requiring Short Courses of Oral Corticosteroids: a Multi-Category Exposure Marginal Structural Models Analysis
Value in Health. 16
2013
Proceedings of the international workshop on cancer advocacy for african countries.
Infectious agents and cancer. 8 Suppl 1 [DOI] 10.1186/1750-9378-8-S1-S1. [PMID] 23902950.
2013
The African cancer advocacy consortium: shaping the path for advocacy in Africa.
Infectious agents and cancer. 8 Suppl 1 [DOI] 10.1186/1750-9378-8-S1-S8. [PMID] 23902674.
2011
Proceedings of the 1st biennial science of global prostate cancer disparities in black men.
Infectious agents and cancer. 6 Suppl 2 [DOI] 10.1186/1750-9378-6-S2-I1. [PMID] 21992588.
2010
Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
The Annals of pharmacotherapy. 44(1):88-96 [DOI] 10.1345/aph.1L289. [PMID] 20040704.
2010
Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?
Epilepsy & behavior : E&B. 19(3):494-500 [DOI] 10.1016/j.yebeh.2010.08.030. [PMID] 20880757.
2007
Constructs underlying community pharmacy dispensing functions relative to Florida pharmacy technicians.
Journal of the American Pharmacists Association : JAPhA. 47(5):588-98 [PMID] 17848348.
View on: PubMed
2007
Physicians’ intent to comply with the American Medical Association’s guidelines on gifts from the pharmaceutical industry.
Journal of medical ethics. 33(6):313-9 [PMID] 17526679.
View on: PubMed
2005
A pharmacist model of perceived responsibility for drug therapy outcomes.
Social science & medicine (1982). 60(10):2393-403 [PMID] 15748686.
View on: PubMed
2004
Predicting physician guideline compliance: an assessment of motivators and perceived barriers.
The American journal of managed care. 10(6):383-91 [PMID] 15209482.
View on: PubMed
2004
Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
PharmacoEconomics. 22(11):751-7 [PMID] 15250752.
View on: PubMed
2003
Reducing claims for prescription drugs with a high potential for abuse.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 60(4):371-4 [PMID] 12625220.
View on: PubMed
2003
Nature of preventable adverse drug events in hospitals: a literature review.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 60(17):1750-9 [PMID] 14503111.
View on: PubMed
2003
A randomized trial of an acid-peptic disease management program in a managed care environment.
The American journal of managed care. 9(6):425-33 [PMID] 12816172.
View on: PubMed
2003
Impact of an antidepressant management program on medication adherence.
The American journal of managed care. 9(1):70-80 [PMID] 12549816.
View on: PubMed
2002
Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59(18):1742-9 [PMID] 12298112.
View on: PubMed
2002
Pharmacoeconomic studies of asthma controller drugs: marketing gimmick or icing on the cake?
Pharmacotherapy. 22(2):131-3 [PMID] 11837550.
View on: PubMed
1999
Influencing physician prescribing.
Pharmacy practice management quarterly. 19(3):30-50 [PMID] 10747681.
View on: PubMed
1997
Applying the principles of pharmaceutical care to the patient with diabetes.
Pharmacy practice management quarterly. 17(2):47-53 [PMID] 10168177.
View on: PubMed
1996
Cost of acid peptic disorders in a managed-care organization.
Clinical therapeutics. 18(2):319-33; discussion 302 [PMID] 8733992.
View on: PubMed
1996
Pharmacoeconomic evaluation of anesthesia in ambulatory surgery: comparison of desflurane to isoflurane and propofol.
Pharmacy practice management quarterly. 16(2):71-85 [PMID] 10172770.
View on: PubMed
1995
Cost of asthma illnesses: emergency department visits without admission.
Pharmacy practice management quarterly. 15(3):72-82 [PMID] 10151715.
View on: PubMed
1995
Evaluating the value, accuracy, and operational feasibility of DUE criteria.
Formulary (Cleveland, Ohio). 30(5):280-3 [PMID] 10151727.
View on: PubMed
1994
A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
Hospital formulary. 29(5):379-82, 388 [PMID] 10136601.
View on: PubMed
1993
Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
American journal of hospital pharmacy. 50(10):2077-81 [PMID] 8238052.
View on: PubMed
1992
A framework for evaluating the work of pharmacists.
Topics in hospital pharmacy management. 12(1):9-19 [PMID] 10128703.
View on: PubMed
1989
Pharmacist-selection methods used by pharmacy managers.
American journal of hospital pharmacy. 46(9):1824-6 [PMID] 2801719.
View on: PubMed

Grants

Sep 2020 ACTIVE
The 6th Biennial Science of Global Prostate Cancer Disparities in Black Men of African Ancestry
Role: Other
Funding: NATL INST OF HLTH NCI
May 2019 ACTIVE
Community Health workers practice improvements – FY1819
Role: Principal Investigator
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Jun 2018 – Jun 2019
Identifying Medication Use Problems and Improving Minority Health through Community Health Workers
Role: Other
Funding: AMER FOU FOR PHARM EDU
Jan 2018 – Jun 2018
Diabetes Self-Management Education Via Telehealth Feasibility Study SOW16-042
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Dec 2017 – Nov 2018
Summer Health Professions Education Program
Role: Project Manager
Funding: ROBERT WOOD JOHNSON FOUNDATION
Jul 2017 – Sep 2018
Medication Therapy Management Support Training Servcies
Role: Principal Investigator
Funding: FL DEPT OF HLTH via CTRS FOR DISEASE CONTROL AND PREVENTION
Sep 2016 – Jun 2017
Community Health workers practice improvements – FY1617
Role: Principal Investigator
Funding: FL DEPT OF HLTH
Sep 2016 – Aug 2017
SCIENCE OF GLOBAL PROSTATE CANCER DISPARITIES
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Sep 2014 – Aug 2019
Florida Minority Cancer Research and Training Center: Feasibility Studies
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI

Education

Ph.D.
1983 · Virginia Commonwealth University‐Medical College of Virginia
M.Sc.
1981 · University of Iowa
ASHP Accredited Residency in Hospital Pharmacy
1976-1977 · Mayo Clinic, Rochester
B.S.
1976 · University of Connecticut

Teaching Profile

Courses Taught
2009-2021
PHA7979 Advanced Research
2009-2021
PHA6910 Supervised Research
2010-2012,2017-2021,2020-2021
PHA6971 Research for Master’s Thesis
2009-2018,2020-2021
PHA7980 Research for Doctoral Dissertation
2009-2016,2020-2021
PHA6935 Selected Topics in Pharmacy
2019-2021
PHA7939 Journal Colloquy in Pharmacodynamics
2015-2021
PHA5103 Prin Pt Centered Care
2010-2013,2016-2021
PHA6228 Institutional Pharmacy Leadership II
2010-2013,2015-2021
PHA6227 Institutional Pharmacy Leadership I
2010-2021
PHA6937 Topics in Pharmaceutical Administration
2010-2012,2015-2020,2018-2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2011,2019-2021
PHA6940 Supervised Teaching
2010-2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2018
PHA5878C Pt Care 3: Cv and Pulm
2009-2015,2017
PHA6266 Introduction to Pharmaceutical Outcomes and Policy II
2014-2016
PHA5742C Pro Commun Pharm Prac
2015
PHA5007 Pharm and Pop Health
2010-2015
PHA6279 Pharmaceutical Outcomes and Policy Seminar
2009-2011,2013-2015
PHA5901 Res Ph Outcome and Plcy
2014-2015
PHA5270 Health Care and Patient Safety
2015
PHA5271 Health Care Risk Management
2012-2014
PHA6291 Pharmaceutical Health Care Systems
2007,2014
PHA6938 Research Seminar
2010,2013-2014
PHA6805 Applied Data Interpretation and Reporting of Findings in Pharmacy
2013
PHA5267 Crit Appr Pharmacoeco
2009-2010
PHA4901 Probs Pharm Outcome
2010
PHA6274 Federal Regulations of Drugs and Pharmacy
2009
PHA6287 Pharmaceutical Health Economics
2008
PHA6717 Measurement in Pharmacy Administration Research

Contact Details

Phones:
Business:
(352) 273-6265
Emails:
Business:
segal@cop.ufl.edu